A study of correlation between Early Heart Failure and dyslipidemia in Newly detected Type 2 diabetes Mellitus populatio

Not Applicable

• Conditions: Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

• Registration Number: CTRI/2023/11/060073
• Lead Sponsor: Dr Gundeti Nikhil

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 19 December 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients age >30 years to 65 years

2.Patients diagnosed with T2DM within 6 months of detection who give informed consent

3.FBS = 126 mg/dL and 2-hr plasma glucose =200mg/dL during an OGTT, RBS = 200 mg/dL with symptoms (polyuria, polydipsia, polyphagia, weight loss) and Hba1c > 6.5 % as per American Diabetes Association recommendations.

Exclusion Criteria

1.Known cases of cardiac diseases- Vascular or Ischemic heart disease, heart failure (congestive cardiac failure), cardiomyopathy, atrial fibrillation on treatment.

2.Known hypertensive patients or patients with BP >130/90 mmHg at the time of diagnosis.

3.Known patients of Chronic kidney disease (eGFR < 60 mL/min/1.73m2)

4.Patients with Chronic pulmonary disease.

5.Patients with Thyroid dysfunction.

6.Patients with Severe Anemia and other Hemoglobinopathies.

7.Known cases of malignancies, on treatment.

8.Pregnant women.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the prevalence of left ventricular diastolic dysfunction in asymptomatic newly detected type 2 Diabetes mellitus. <br/ ><br>To study the correlation of left ventricular diastolic dysfunction with dyslipidemia in asymptomatic newly detected type 2 Diabetes mellitus. <br/ ><br> <br/ ><br>Timepoint: At the time of recruitement <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
To study the correlation of left ventricular diastolic dysfunction with Glycosylated Hemoglobin levels in asymptomatic newly detected type 2 Diabetes mellitus.Timepoint: At the time of recruitement <br/ ><br>